David W. Nassif Sio Gene Therapies Inc. (SIOX) insider trading activity

SIOX Quotes by TradingView

David W. Nassif is Interim CEO, CFO of Sio Gene Therapies Inc.. Currently has a direct ownership of 45,244 shares of SIOX, which is worth approximately $0. The most recent transaction as insider was on Dec 08, 2021, when has been sold 6,294 shares (Common Stock) at a price of $1.42 per share, resulting in proceeds of $8,937. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.2K
0% 3M change
0% 12M change
Total Value Held $0

David W. Nassif Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 08 2021
SELL
Payment of exercise price or tax liability
$8,937 $1.42 p/Share
6,294 Reduced 12.21%
45,244 Common Stock
Dec 08 2021
BUY
Grant, award, or other acquisition
-
17,534 Added 25.39%
51,538 Common Stock
Mar 22 2021
BUY
Grant, award, or other acquisition
-
15,060 Added 30.69%
34,004 Common Stock
DWN

David W. Nassif

Interim CEO, CFO
New York, NY

Track Institutional and Insider Activities on SIOX

Follow Sio Gene Therapies Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SIOX shares.

Notify only if

Insider Trading

Get notified when an Sio Gene Therapies Inc. insider buys or sells SIOX shares.

Notify only if

News

Receive news related to Sio Gene Therapies Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SIOX